`

Janux Therapeutics

Biotechnology Research

Specialities :
Biotechnology
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$296.5M
size-icon Size
51 - 200

Frequently Asked Questions About Janux Therapeutics

What does Janux therapeutics do?+

Janux is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Januxs proprietary technology enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The goal of both platforms is to provide cancer patients with safe and effective therapeutics that direct and guide their immune system to eradicate tumors while minimizing safety concerns. Janux is currently developing a broad pipeline of TRACTr and TRACIr therapeutics directed at several targets to treat solid tumors. Janux has two TRACTr therapeutic candidates in clinical trials, the first targeting PSMA is in development for prostate...

What are Janux therapeutics's specialties? +

Biotechnology

What is Janux therapeutics's industry? +

Janux therapeutics operates in the Biotechnology research industry.

What is Janux therapeutics's revenue? +

Janux therapeutics's revenue is 11m - 100m

What is Janux therapeutics's company size? +

Janux therapeutics has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.